Friday night Pandemic Watch - Swine Flu coming to you?

[alwyn]

I think the really disturbing thing here is the live viruses that were shipped on a train and escaped. There appears to be more mortality on the other side of the world from it. I'm wondering if there are two events going on, one bio-engineered, and one 'native'...

just paranoid

Found this today...off Rense, so consider the source, but it's sourced to other links, which see...

Has Baxter Released A
BioWeapon In Ukraine?
By David Rothscum
11-2-9


Evidence appears to suggest that Baxter International may be responsible for a new deadly outbreak of viral pneumonia in Ukraine.

(http://www.bloomberg.com/apps/news?pid= ... o3LbhcA75I) In February of 2009, Bloomberg reported that Baxter "accidentally" sent vaccine material containing both live Avian bird flu and seasonal influenza to multiple laboratories worldwide. A laboratory decided to test the vaccine on its ferrets and the ferrets all unexpectedly died.

(http://www.bloomberg.com/apps/news?pid= ... o3LbhcA75I) http://www.bloomberg.com/apps/news?pid= ... o3LbhcA75I

It must be noted that Baxter has made a "mistake" like this before. (http://www.aegis.com/news/re/1996/RE960283.html) Blood products produced by Baxter once containd HIV. Thousands of haemophiliacs died due to this, and many went on to infect their spouses.

http://www.aegis.com/news/re/1996/RE960283.html

Later in the year, a bizarre story emerged on the internet. The news was full of reports on (http://www.huffingtonpost.com/2009/08/1 ... 59330.html) a man named Joseph Moshe who was arrested after a hours long standoff with the police because he had supposedly made threats against the White House. The man was able to withstand multiple rounds of tear gas...which left L.A. police officers amazed.

However, the internet community was very skeptical of the true reasons behind the man's arrest. Comments on the Huffington Post website immediately began pouring in about an unreported side to this story, namely that Joseph Moshe was a Mossad Agent who specialized in biological warfare and who called into a radio show to warn people about a biological weapn that was being made by Baxter international that would be spread through vaccine and would cause a plague upon its release.

Although anyone can make a doomsday claim and we should never believe anyone (and it must be said that the Truth movement handled this well, the message was spread without being proclaimed as gospel) the amazing part about Moshe's claim was the location where Moshe said the biological weapon was being produced.

Moshe claimed that Baxter's laboratory in the Ukraine out of all places was creating this biological weapon. All of this came out in the beginning of August, which is more than 2 months before the situation that is currently unfolding. For Moshe to correctly name the country where a new epidemic would be unleashed, requires either inside information, or an incredible coincidence as anyone with a basic knowledge of statistics can confirm for himself.

Let us assume for a moment that every person on our planet has an equal chance of giving rise to a new lethal epidemic due to a virus that mutates as it spreads through his body. (http://www.ukrstat.gov.ua/operativ/oper ... 609_e.html)


(http://www.ukrstat.gov.ua/operativ/oper ... 609_e.html) Ukraine has 46 million inhabitants. (http://www.census.gov/ipc/www/popclockworld.html) The current estimated global population is about 6.7 billion. This means that if a new epidemic were to arise, the chance of this epidemic starting in the Ukraine would be 0.69%. (http://zik.com.ua/en/news/2009/10/29/202374) However, it appears that this virus is a form of flu. This makes the odds of being right when guessing that a deadly flu is going to break out in the Ukraine even smaller. The reason for this is that back in early August the vast majority of influenza infections were found in different countries than the Ukraine. (http://www.earthtimes.org/articles/show/292540,
ukraine-confirms-first-swine-flu-death-quarantine-ordered.html) In fact, on 30 Oktober, Earthtimes reported that Ukraine had officially reported only two cases of swine flu, and no deaths, until last Friday. This deadly epidemic appears to have arrived out of nowhere in the Ukraine.
(http://www.biomedexperts.com/Profile.bm ... Bar-Joseph)


(http://www.biomedexperts.com/Profile.bm ... Bar-Joseph) Moshe's biomed profile appears to confirm his position as a microbiologist. Furthermore, this page with Baxter's contact information for its Ukraine office confirms that Baxter has a presence in the Ukraine.

http://www.biomedexperts.com/Profile.bm ... Bar-Joseph

(http://www.stevequayle.com/dead_scienti ... tists.html) It must also be noted that massive numbers of microbiologists have been dying bizarre deaths. This case of what appears to be a brave man who sacrificed it all to bring us this message may explain why so many microbiologists have been murdered. The fact that this man managed to predict an outbreak of highly lethal influenza in a place where we would least expect it, 2 months before it a actually occured, lends credence to his claim that Baxter International is responsible for the outbreak and shows that top microbiologists can pose a problem to the people responsible for this ongoing disaster.

This is a developing story, expect to see possible updates on David Rothscum Reports as more information on what is happening in Ukraine becomes available.

Update 1: For the purpose of keeping information from disappearing, I am going to mirror most information I can find on here.

Comments on the Huffington post website on an article about Moshe's arrest documenting his claim that the Influenza virus in a vaccine manufactured by Baxter in Ukraine replicates RNA from the 1918 flu and is meant as a bioweapon:

(http://www.infowars.com/images/josephmosheukraine.JPG)

Update 2: (http://www.google.com/hostednews/afp/ar ... DSaDdjU9kw) The Ukrainian government wants to impose travel restrictions on people across the nation to stop the virus from spreading.

Update 3: According to the Huffington post comments I cited above, Dr. Moshe claimed that the virus used replicated RNA of the 1918 Spanish flu. (http://www.history.navy.mil/library/online/influenza%
20phil%201918.htm) Symptoms of the 1919 Flu include victims being drenched in blood:

American were familiar with the flu; it sent you to bed, made you miserable for 3 or 4 days with fever, muscle aches, and congestion, then left you shaky for about a week. It made millions sick, yet killed only the oldest, youngest, and most feeble.

The 1918 influenza was not the flu Americans were familiar with. It was a horror that turned victims bluish-black then drowned them with their own body fluids. the death toll was highest in the ages 15 to 40, those in the peak of health. The victims would be fine one minute and the next incapacitated, fever-racked, and delirious. Temperatures rose to 104-106 degrees, skin turned blue, purple, or deep brown from lack of oxygen. Massive pneumonia attacked the lungs, filling them with fluid; blood gushed from the nose. Death was quick, savage, and terrifying.

(http://zik.com.ua/en/news/2009/10/29/202374) Compare this to reports that are coming out from Ukraine:

Five persons have died from the flue in Lviv, four men and one woman, says emergency hospital chief doctor Myron Borysevych.

Two of the dead patients were in the 22-35 age group, with 2 others over 60. He diagnosed the disease as viral pneumonia.

Viral tests can last from one to two weeks. They are complicated and not done in Lviv. The course of the disease was very quick. The symptoms included very high temperature and short-wind cough.

All the six dead young people had symptoms of severe hemmorhagic pneumonia. The disease starts slowly, with temperature rising to 37.2 ­ 37.3 degrees, slight cough and pain in joints. Nasal catarrh developed at the end of the second or third day. Autopsy revealed that the lungs were soaked with blood, the oblast chief specialist said.

[stickdog99]

I don't know, whipstitch. They've said all along that their worry was that this could mutate. They've known since late spring, early summer that this one was extremely, extremely transmissible. And that's one of the things that had them worried, it mutating and becoming more deadly as well as maintaining its transmissibility.

There are links in earlier pages about flu's ability to mutate. Just because it didn't in the southern hemisphere, where they've finished out their winter doesn't mean that it can't mutate in the blink of an eye up here.

And if it mutates, how will any vaccine protect us against the mutated version?

Happy Halloween!

[stickdog99]

It pays to read the fine print:

http://www.fda.gov/downloads/BiologicsB ... 182401.pdf

5 mL multi-dose vial containing ten doses. Thimerosal, a mercury derivative, is added as a preservative; each 0.5 mL dose contains 24.5 micrograms (mcg) of mercury.

...

Pregnancy Category C: Animal reproduction studies have not been conducted with Influenza A (H1N1) 2009 Monovalent Vaccine or AFLURIA. It is also not known whether these vaccines can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Influenza A (H1N1) 2009 Monovalent Vaccine should be given to a pregnant woman only if clearly needed.

...

Neither Influenza A (H1N1) 2009 Monovalent Vaccine nor AFLURIA has been evaluated in children. Safety and effectiveness in the pediatric population have not been established.

...

Influenza A (H1N1) 2009 Monovalent Vaccine, for intramuscular injection, is a sterile, clear, colorless to slightly opalescent suspension with some sediment that resuspends upon shaking to form a homogeneous suspension. Influenza A (H1N1) 2009 Monovalent Vaccine is prepared from influenza virus propagated in the allantoic fluid of embryonated chicken eggs. Following harvest, the virus is purified in a sucrose density gradient using a continuous flow zonal centrifuge. The purified virus is inactivated with beta-propiolactone, and the virus particles are disrupted using sodium taurodeoxycholate to produce a “split virion”. The disrupted virus is further purified and suspended in a phosphate buffered isotonic solution.

Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg HA per 0.5 mL dose of influenza A/California/7/2009 (H1N1)v-like virus.

The single-dose formulation is preservative-free; thimerosal, a mercury derivative, is not used in the manufacturing process for this formulation. The multi-dose formulation contains thimerosal, added as a preservative; each 0.5 mL dose contains 24.5 mcg of mercury.

A single 0.5 mL dose of Influenza A (H1N1) 2009 Monovalent Vaccine contains sodium chloride (4.1 mg), monobasic sodium phosphate (80 mcg), dibasic sodium phosphate (300 mcg), monobasic potassium phosphate (20 mcg), potassium chloride (20 mcg), and calcium chloride (1.5 mcg). From the manufacturing process, each dose may also contain residual amounts of sodium taurodeoxycholate (≤ 10 ppm), ovalbumin (≤ 1 mcg), neomycin sulfate (≤ 0.2 picograms [pg]), polymyxin B (≤ 0.03 pg), and beta-propiolactone (< 25 nanograms).

...

Neither Influenza A (H1N1) 2009 Monovalent Vaccine nor AFLURIA has been evaluated for carcinogenic or mutagenic potential or for impairment of fertility.

[stickdog99]

More fine print:

http://www.fda.gov/downloads/BiologicsB ... 182242.pdf

Multidose vial, 5-mL. Contains thimerosal, a mercury derivative (25 mcg mercury per 0.5-mL dose). Thimerosal is added as preservative. (3,11)

...

In 1987 a clinical study was carried out in 38 ‘at risk’ children aged between 4 and 12 years (17 females and 21 males). To record the safety of FLUVIRIN, participants recorded their symptoms on a diary card during the three days after vaccination and noted any further symptoms they thought were attributable to the vaccine. The only reactions recorded were tenderness at the site of vaccination in 21% of the participants on day 1, which was still present in 16% on day 2 and 5% on day 3. In one child, the tenderness was also accompanied by redness at the site of injection for two days. The reactions were not age-dependent and there was no bias towards the younger children.
Three clinical studies were carried out between 1995 and 2004 in a total of 520 pediatric subjects (age range 6 - 47 months). Of these, 285 healthy subjects plus 41 ‘at risk’ subjects received FLUVIRIN. No serious adverse events were reported.

...

Adverse events described here are included because: a) they represent reactions which are known to occur following immunizations generally or influenza immunizations specifically; b) they are potentially serious; or c) the frequency of reporting.

•Body as a whole: Local injection site reactions (including pain, pain limiting limb movement, redness, swelling, warmth, ecchymosis, induration), hot flashes/flushes; chills; fever; malaise; shivering; fatigue; asthenia; facial edema.

•Immune system disorders: Hypersensitivity reactions (including throat and/or mouth edema). In rare cases, hypersensitivity reactions have lead to anaphylactic shock and death.

•Cardiovascular disorders: Vasculitis (in rare cases with transient renal involvement), syncope shortly after vaccination.

•Digestive disorders: Diarrhea; nausea; vomiting; abdominal pain.

•Blood and lymphatic disorders: Local lymphadenopathy; transient thrombocytopenia.

•Metabolic and nutritional disorders: Loss of appetite.

•Musculoskeletal: Arthralgia; myalgia; myasthenia.

•Nervous system disorders: Headache; dizziness; neuralgia; paraesthesia; confusion; febrile convulsions; Guillain-Barré Syndrome; myelitis (including encephalomyelitis and transverse myelitis); neuropathy (including neuritis); paralysis (including Bell’s Palsy).

•Respiratory disorders: Dyspnea; chest pain; cough; pharyngitis; rhinitis.

•Skin and appendages: Stevens-Johnson syndrome; sweating; pruritus; urticaria; rash (including non-specific, maculopapular, and vesiculobulbous).

...

Pregnancy Category C: Animal reproduction studies have not been conducted with Influenza A (H1N1) 2009 Monovalent Vaccine or FLUVIRIN. It is also not known whether Influenza A (H1N1) 2009 Monovalent Vaccine or FLUVIRIN can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Influenza A (H1N1) 2009 Monovalent Vaccine should be given to a pregnant woman only if clearly needed.

...

Safety and effectiveness in pediatric subjects below the age of 4 years have not been established.

...

Influenza A (H1N1) 2009 Monovalent Vaccine is a sub-unit (purified surface antigen) influenza virus vaccine prepared from virus propagated in the allantoic cavity of embryonated hens’ eggs inoculated with a specific type of influenza virus suspension containing neomycin and polymyxin. The influenza virus strain is harvested and clarified by centrifugation and filtration prior to inactivation with betapropiolactone. The inactivated virus is concentrated and purified by zonal centrifugation. The surface antigens, hemagglutinin and neuraminidase, are obtained from the influenza virus particle by further centrifugation in the presence of nonylphenol ethoxylate, a process which surface antigen preparation.
Influenza A (H1N1) 2009 Monovalent Vaccine is a homogenized, sterile, slightly opalescent suspension in a phosphate buffered saline. Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg hemagglutinin (HA) per 0.5-mL dose of the following virus strain: A/California/7/2009 (H1N1)v-like virus.

The 0.5-mL prefilled syringe presentation is formulated without preservative. Thimerosal, a mercury derivative used during manufacturing, is removed by subsequent purification steps to a trace amount (<= 1 mcg mercury per 0.5-mL dose).

The 5-mL multidose vial formulation contains thimerosal, a mercury derivative, added as a preservative. Each 0.5-mL dose from the multidose vial contains 25 mcg mercury.

Each dose from the multidose vial or from the prefilled syringe may also contain residual amounts of egg proteins (<= 1 mcg ovalbumin), polymyxin (<= 3.75 mcg), neomycin (<= 2.5 mcg), betapropiolactone (not more than 0.5 mcg) and nonylphenol ethoxylate (not more than 0.015% w/v).

...

Neither FLUVIRIN nor the Influenza A (H1N1) 2009 Monovalent Vaccine have been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.

[Nordic]

And if it mutates, how will any vaccine protect us against the mutated version?

Happy Halloween!

HA!

Thanks for the voice of reason, Stickdog, and your following post as well.

Yup, it's all spelled out there, isn't it.

The complete lack of safety testing, and the only immunity from it seems to be for the pharmaceutical companies -- immunity against lawsuits from medical problems due to the vaccine.

Nice job, companies!

Let's look at the recipe:

a. Corrupt the CDC (how this happened is still a mystery)

b. Discover a "new" strain of flu, "market" it with a very similar name as the truly deadly "avian" flu virus. H51V, H42Z, whatever, they all sound the same.

c. Ratchet up the fear of it, name it after an animal that people associate with dirt and bad smells and other bad connotations -- "SWINE".

d. Invent all kinds of crazy numbers about how dangerous it is.

e. Come up with the "WE'LL SAVE YOU" scenario, whereby a vaccine is created, rushed to the market, completely untested. But NO PROBLEMO, the so-called "Government" will help you by granting you complete immunity from any lawsuits resulting from the fact that this vaccine was completely untested.

f. Conspire with the PTB to do whatever else you want to do with this vaccine -- "Hey, we're about to inject half the population of the world with this new vaccine. Got anything you want added to it?"

g. Drum up fear that it's NOT going to be available to EVERYONE -- thus making everyone literally line up for HOURS to get one.

h. Charge accordingly.

i. Count the money and laugh all the way to the bank.

j. Repeat as necessary.

Pretty simple, really.

To me, the only mystery is how the CDC got so corrupted. Maybe it was the deaths of all those microbiologists? Just a guess.

[stickdog99]

More fine print:

http://www.fda.gov/downloads/BiologicsB ... 182404.pdf

Multi-dose vial, 5 mL, contains thimerosal, a mercury derivative, added as a preservative. Each 0.5 mL dose contains 25 mcg mercury.

...

Sanofi Pasteur’s Influenza A (H1N1) 2009 Monovalent Vaccine and seasonal trivalent Influenza Virus Vaccine (Fluzone®) are manufactured by the same process. The following sub-sections summarize safety data from clinical experience with seasonal trivalent inactivated influenza vaccines, including Fluzone vaccine.

Adverse event information from clinical trials provides the basis for identifying adverse events that appear to be related to vaccine use and for approximating the rates of these events. However, because clinical trials are conducted under widely varying conditions, adverse event rates observed in the clinical trials of a vaccine cannot be directly compared to rates in the clinical trial of another vaccine, and may not reflect the rates observed in practice.

...

Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to vaccine exposure.

Blood and Lymphatic System Disorders: Thrombocytopenia, lymphadenopathy

Immune System Disorders: Anaphylaxis, other allergic/hypersensitivity reactions (including urticaria, angioedema)

Nervous System Disorders: GBS, convulsions, myelitis (including encephalomyelitis and transverse myelitis), facial palsy (Bell’s palsy), optic neuritis/neuropathy, brachial neuritis, syncope (shortly after vaccination), dizziness, paresthesia

Vascular Disorders: Vasculitis, vasodilation/flushing

Respiratory, Thoracic and Mediastinal Disorders: Dyspnea, pharyngitis, rhinitis

Skin and Subcutaneous Tissue Disorders: Stevens-Johnson syndrome

General Disorders and Administration Site Conditions: Fever, pain, pruritis, asthenia/fatigue, pain in extremities, chest pain

...

Sanofi Pasteur’s Influenza A (H1N1) 2009 Monovalent Vaccine and seasonal trivalent Influenza Virus Vaccine (Fluzone vaccine) are manufactured by the same process. Available information for Fluzone vaccine is provided in this section.

Pregnancy Category C: Animal reproduction studies have not been conducted with Influenza A (H1N1) 2009 Monovalent Vaccine or Fluzone vaccine. It is also not known whether these vaccines can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Influenza A (H1N1) 2009 Monovalent Vaccine should be given to a pregnant woman only if clearly needed.

Pediatric Use

Safety and effectiveness in pediatric subjects below the age of 6 months have not been established. The immune response and safety of Fluzone vaccine was evaluated in 31 children between the ages of 6-26 months.

...

Influenza A (H1N1) 2009 Monovalent Vaccine, an inactivated influenza virus vaccine, for intramuscular use, is prepared from influenza viruses propagated in embryonated chicken eggs. The virus-containing allantoic fluid is harvested and inactivated with formaldehyde. Influenza virus is concentrated and purified in a linear sucrose density gradient solution using a continuous flow centrifuge. The virus is then chemically disrupted using a non-ionic surfactant, polyethylene glycol p-isooctylphenyl ether (Triton® X-100), producing a “split virus”. The split virus is further purified and then suspended in sodium phosphate-buffered isotonic sodium chloride solution.

Influenza A (H1N1) 2009 Monovalent Vaccine is formulated to contain 15 mcg hemagglutinin (HA) of influenza A/California/07/2009 (H1N1) v-like virus per 0.5 mL dose. Gelatin 0.05% is added as a stabilizer. Each 0.5 mL dose may contain residual amounts of formaldehyde (not more than 100 mcg), polyethylene glycol p-isooctylphenyl ether (not more than 0.02%), and sucrose (not more than 2.0%).

There is no thimerosal used in the manufacturing process of the single-dose presentations of Influenza A (H1N1) 2009 Monovalent Vaccine. The multi-dose presentation of Influenza A (H1N1) 2009 Monovalent Vaccine contains thimerosal, a mercury derivative, added as a preservative. Each 0.5 mL dose of the multidose presentation contains 25 mcg mercury.

...

Neither Fluzone vaccine nor Influenza A (H1N1) 2009 Monovalent Vaccine have been evaluated for carcinogenic or mutagenic potential, or for impairment of fertility.

[alwyn]

b. Discover a "new" strain of flu, "market" it with a very similar name as the truly deadly "avian" flu virus. H51V, H42Z, whatever, they all sound the same.

to be fair: All flu viruses — human, bird, pig — have an “H” and an “N” in the name, each followed by a number (the avian flu strain that has been worrying people is H5N1, for example).

The letters refer to two proteins (hemagglutinin and neuraminidase) on the surface of the virus. The numbers refer to slight variations in the form of each protein. The variations are important, because our immune system hones in on those proteins to attack the virus.

As it turns out, human strains of H1N1 flu are also pretty common. In fact, the vaccine used for the flu season that’s just ending protected against a strain of human H1N1 virus. But unfortunately, because of differences between the human and swine versions of the flu, the human vaccine doesn’t appear to protect against swine H1N1.

[stickdog99]

Does the vaccine matter?

[23]

Does the vaccine matter?

Of course it does.

http://peacerebelgirl.wordpress.com/200 ... e-program/

8 billion dollars is a lot of moolah for Big Pharma.

Of course it matters to them.

[stickdog99]

The money quote:

In Jefferson’s view, this raises a troubling conundrum: Is vaccine necessary for those in whom it is effective, namely the young and healthy? Conversely, is it effective in those for whom it seems to be necessary, namely the old, the very young, and the infirm? These questions have led to the most controversial aspect of Jefferson’s work: his call for placebo-controlled trials, studies that would randomly give half the test subjects vaccine and the other half a dummy shot, or placebo. Only such large, well-constructed, randomized trials can show with any precision how effective vaccine really is, and for whom.

In the flu-vaccine world, Jefferson’s call for placebo-controlled studies is considered so radical that even some of his fellow skeptics oppose it. Majumdar, the Ottawa researcher, says he believes that evidence of a benefit among children is established and that public-health officials should try to protect seniors by immunizing children, health-care workers, and other people around them, and thus reduce the spread of the flu.

Lone Simonsen explains the prevailing view: “It is considered unethical to do trials in populations that are recommended to have vaccine,” a stance that is shared by everybody from the CDC’s Nancy Cox to Anthony Fauci at the NIH. They feel strongly that vaccine has been shown to be effective and that a sham vaccine would put test subjects at unnecessary risk of getting a serious case of the flu. In a phone interview, Fauci at first voiced the opinion that a placebo trial in the elderly might be acceptable, but he called back later to retract his comment, saying that such a trial “would be unethical.” Jefferson finds this view almost exactly backward: “What do you do when you have uncertainty? You test,” he says. “We have built huge, population-based policies on the flimsiest of scientific evidence. The most unethical thing to do is to carry on business as usual.”

Name another "science" in which a controlled experiment would be deemed radical and unethical.

[Sweejak]

Via Brasscheck, Swine Flu Government Data Scam:

http://www.brasschecktv.com/page/731.html

[stickdog99]

http://wonder.cdc.gov/controller/datare ... E930FADADD

Adverse H1N1 Vaccine Effects Self-Reported So Far

3 Deaths
7 Life Threatening Events
12 Hospitalizations
204 Emergency Room visits
667 Not Serious

893 total adverse events reported so far vs. no documented benefit

[lightningBugout]

http://wonder.cdc.gov/controller/datarequest/D8;jsessionid=3918F0951BF760A23BFCAEE930FADADD

Adverse H1N1 Vaccine Effects Self-Reported So Far

3 Deaths
7 Life Threatening Events
12 Hospitalizations
204 Emergency Room visits
667 Not Serious

893 total adverse events reported so far vs. no documented benefit

There have been over 10,000,000 doses given in the states alone. The people who died almost certainly died from anaphylactic shock reactions due to the egg protein in the vaccine.

[stickdog99]

http://wonder.cdc.gov/controller/datarequest/D8;jsessionid=3918F0951BF760A23BFCAEE930FADADD

Adverse H1N1 Vaccine Effects Self-Reported So Far

3 Deaths
7 Life Threatening Events
12 Hospitalizations
204 Emergency Room visits
667 Not Serious

893 total adverse events reported so far vs. no documented benefit

There have been over 10,000,000 doses given in the states alone. The people who died almost certainly died from anaphylactic shock reactions due to the egg protein in the vaccine.

And of these 10 million people, how many benefited how much by not getting the H1N1 they may or may not have contracted without the shot? Isn't that number completely unknown?

This is the trouble with current vaccination "studies" (of which none at all were run for the new H1N1 vaccines). You need to do a blind, longitudinal placebo controlled trial of thousands of subjects to scientifically demonstrate that the medical benefits of these vaccines definitely outweigh their risks. But since this is assumed to be the case without any scientific proof, any such studies are deemed unethical and irresponsible.

[lightningBugout]

http://wonder.cdc.gov/controller/datarequest/D8;jsessionid=3918F0951BF760A23BFCAEE930FADADD

Adverse H1N1 Vaccine Effects Self-Reported So Far

3 Deaths
7 Life Threatening Events
12 Hospitalizations
204 Emergency Room visits
667 Not Serious

893 total adverse events reported so far vs. no documented benefit

There have been over 10,000,000 doses given in the states alone. The people who died almost certainly died from anaphylactic shock reactions due to the egg protein in the vaccine.

And of these 10 million people, how many benefited how much by not getting the H1N1 they may or may not have contracted without the shot? Isn't that number completely unknown?

This is the trouble with current vaccination "studies" (of which none at all were run for the new H1N1 vaccines). You need to do a blind, longitudinal placebo controlled trial of thousands of subjects to scientifically demonstrate that the medical benefits of these vaccines definitely outweigh their risks. But since this is assumed to be the case without any scientific proof, any such studies are deemed unethical and irresponsible.

Neither of us have any way to know that. The point being, even if you wholly believed the vaccine was a good thing, the numbers would stand. And these numbers actually support the case that the vaccine is statistically exceptionally safe. Chances are that some of the people who died from the vaccine would have died from anaphylaxis anyways.